Gregory P. Kalemkerian

Papers

1

Total Citations

4

H-Index

1

About

Gregory P. Kalemkerian is a leading authority in thoracic oncology, with a focused expertise in the management of lung cancer and other thoracic malignancies. His major contributions center on advancing the clinical understanding and treatment of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), particularly through the development of evidence-based guidelines and comprehensive clinical resources. As the editor of the seminal *Handbook of Lung Cancer and Other Thoracic Malignancies* (2016), he synthesized critical knowledge for practitioners, shaping standard-of-care approaches. His work has been widely cited, reflecting its deep impact on clinical decision-making and research directions. Beyond his publications, Kalemkerian is recognized for his leadership in national oncology committees, where he has influenced treatment protocols and educational initiatives. His dedication to translating complex research into practical, patient-centered care has made him a trusted voice in the field, guiding both seasoned clinicians and trainees through the evolving landscape of thoracic cancer therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Handbook of Lung Cancer and Other Thoracic Malignancies
4 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 30

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago